A Registry Study for Emergency Medical Service of Aneurysmal Subarachnoid Hemorrhage in China
Launched by XUANWU HOSPITAL, BEIJING · Apr 10, 2017
Trial Information
Current as of May 10, 2025
Completed
Keywords
ClinConnect Summary
For this study, the investigators consulted and hired professionals and experts about data collection, data analysis and methodology. So it has an intact systematic Project Steering Committee for the whole project, including Data Monitoring Committee, Data Management Committee, Project Academic Committee, Executive Group, Project Manager, Project Statistician,Technical Support Center. Also the project have a scientific regulations system.
Steering Committee: To monitor and supervise the progress of the Registry Study for Emergency Medical Service of Aneurysmal Subarachnoid Hemorrhage With ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Proven subarachnoid haemorrhage on computed tomography(CT) or lumbar puncture less than 14 days.
- • 2. Exist at least one target intracranial aneurysm demonstrated by computed tomography angiography (CTA) or Digital Subtraction Angiography(DSA).
- • 3. Age is older than 14 years old.
- • 4. Patient or relatives agreed to sign the consent form.
- Exclusion Criteria:
- • 1. Some special types of controversial aneurysmal subarachnoid hemorrhage such as caused by blood blister-like aneurysm,dissection aneurysm and so on.
- • 2. Participation in another randomised drug or clinical trial for subarachnoid hemorrhage.
- • 3. Refusal of consent.
- • 4. Women during pregnancy.
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Beijing, Beijing, China
Patients applied
Trial Officials
Hongqi Zhang, PhD. M.D
Principal Investigator
Xuanwu hosptial,Capital Medical University,China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials